Hugh Sowley PhD
As a Consultant at Cambridge Healthcare Research, Hugh has worked in the Generics & Biosimilars team as well leading projects in the Branded & Innovator Product division, and has supported monitoring projects focused on autoimmune and CNS diseases. Hugh also regularly attends international medical congresses leading CHR teams on the ground to get the latest insights from key disease area experts, forecasting how the indication is evolving, and what understanding the factors affecting change on the treatment algorithm.
Prior to CHR, Hugh was at Imperial College London where he gained a PhD in chemical biology and worked as a post-doc researcher developing novel laser-based techniques to study drug-protein interactions.
Outside of work, Hugh enjoys playing and watching football, good food, and literature.